SU1268168A1 - Method of treatment of destructive pulmonary tuberculosis - Google Patents
Method of treatment of destructive pulmonary tuberculosis Download PDFInfo
- Publication number
- SU1268168A1 SU1268168A1 SU823433553A SU3433553A SU1268168A1 SU 1268168 A1 SU1268168 A1 SU 1268168A1 SU 823433553 A SU823433553 A SU 823433553A SU 3433553 A SU3433553 A SU 3433553A SU 1268168 A1 SU1268168 A1 SU 1268168A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- pulmonary tuberculosis
- months
- closure
- decay
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относитс к медицине и предназначено дл лечени дест руктивного туберкулеза легких. Цель изобретени - сокращение сроков лечени и увеличение процента закрыти полостей распада. Больному назначают туберкулостатические препараты и дополнительно ввод т 5%-ный унитиол ежедневно по 5 мп. Бактериовьщеление прекращаетс через 1-2 мес При рентгенотомографии через 2-5 мес, отмечаетс закрытие полостей распада и почти полное рассасывание воспалительi ных и-зменений. (Л СThis invention relates to medicine and is intended for the treatment of pulmonary pulmonary tuberculosis. The purpose of the invention is to reduce the duration of treatment and increase the percentage of closure of the decay cavities. Tuberculostatic drugs are prescribed to the patient and additionally 5% unithiol is administered daily at 5 mp. Bacteriolysis ceases after 1-2 months. With an x-ray tomography after 2-5 months, closure of the decay cavities and the almost complete resorption of inflammatory changes are observed. (Ls
Description
Изобретение относитс к медицине и может быть использовано дл деструктивного туберкулеза легкихThe invention relates to medicine and can be used for destructive pulmonary tuberculosis.
Цель изобретени - сокращение срков лечени и увеличение процента закрыти полостей распадаThe purpose of the invention is to reduce the treatment time and increase the percentage of closure of the decay cavities.
Пример 1. Больной У, 51 год, находилс на лечении с пер вично вы вленным инфильтративным туберкулезом легких в фазе распада с локализацией полостей распада в верхней доле легкого справа Боль-™ ному назначены туберкулостатические препараты - изониазид по 0,6 г внутрь, стрептомицин по 1,0 гвнутримышечно Дополнительно ежедневно больному вводили внутримьшечно по 5 мл раствора унитиола. Пол ный курс медикаментозной терапии составил 65,7 г изониазида, 24,3 г стрептомицина и 85 инъекций унитио ла. Прекращение бактериовьщелени отметили уже через I мес. При рент :генотомографии через 2 мес устано вили почти полное рассасывание воспалительных изменений, перестала определ тьс полость распада. Больной вьтисан на санаторное долечива ние .Example 1. Patient U, 51, was treated with primary infiltrative pulmonary tuberculosis in the decay phase with localization of decay cavities in the upper lobe of the lung on the right. He was prescribed 0.6 g of isoniazid orally, streptomycin. 1.0 intramuscularly Additionally, 5 ml of unitiol solution was injected intramuscularly to the patient daily. The full course of drug therapy was 65.7 g of isoniazid, 24.3 g of streptomycin and 85 injections of unitio. Termination of bacteriovascularization was noted already after I month. In case of rent: genotomography, after 2 months, an almost complete resorption of inflammatory changes was established, the decay cavity was no longer determined. The patient was introduced for sanatorium treatment.
Пример 2. Больной С., 19 лет, находилс на лечении по поводу инфильтративного туберкулезаExample 2. Patient S., 19 years old, was on treatment for infiltrative tuberculosis
6816868168
легких в фазе распада и обсеменени , диффузного двустороннего гнойного эндобронхита. В мокроте обнаружены микробактерии туберкулеза. Больномуlungs in the phase of decay and contamination, diffuse bilateral purulent endobronchitis. In the sputum, tuberculosis microbes are found. To the patient
5 назначен изониазид по 0,6 г и этам- бутол по 1,2 в день. Дополнительно ежедневно больному внутримьшечно вводили по 5 мл 5%-ного раствора унитиола. Всего проведено 54 инъек-5 isoniazid 0.6 g each and etam-butol 1.2 each day. Additionally, 5 ml of 5% solution of unithiol was administered intramuscularly to the patient daily. A total of 54 injections were made.
О ции унитиолао Бактериовьщеление прекратилось через 2 мес. При рентгено- томографии закрытие полостей распада отмечено через 5 мес лечени при почти полном рассасывании оча15 гов обсеменени и инфильтрации.About the Unithiolao Bacteriolysis stopped after 2 months. With X-ray tomography, the closure of the decay cavities was observed after 5 months of treatment, with almost complete resorption of the sites of seeding and infiltration.
Предлагаемый способ лечендс . позвол ет сократить ороки лечени больных с деструктивным туберкулезом легких с 5-6 мес по известному способуThe proposed method of treatment. allows to reduce oroci treatment of patients with destructive pulmonary tuberculosis from 5-6 months by a known method
20 до 3-4 мес и увеличить процент закрыти полостей распада с 35 до 61%.20 to 3-4 months and increase the percentage of closure of the decay cavities from 35 to 61%.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU823433553A SU1268168A1 (en) | 1982-05-04 | 1982-05-04 | Method of treatment of destructive pulmonary tuberculosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU823433553A SU1268168A1 (en) | 1982-05-04 | 1982-05-04 | Method of treatment of destructive pulmonary tuberculosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1268168A1 true SU1268168A1 (en) | 1986-11-07 |
Family
ID=21010240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU823433553A SU1268168A1 (en) | 1982-05-04 | 1982-05-04 | Method of treatment of destructive pulmonary tuberculosis |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1268168A1 (en) |
-
1982
- 1982-05-04 SU SU823433553A patent/SU1268168A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Проблемы туберкулеза, 1981, № 10, с. 9-12. Совершенствование лечебной помощи больным туберкулезом органов дыхани . М., 1981, с. 5-8. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94046316A (en) | Use of high effective phosphonates for preparing medicinal agents for osteoporosis treatment | |
| KR910005858A (en) | Fatty acid therapy | |
| EP0290262A3 (en) | Improved nitrate therapy for angina pectoris | |
| SU1268168A1 (en) | Method of treatment of destructive pulmonary tuberculosis | |
| COHEN et al. | Use of a calcium chelating agent (NaEDTA) in cardiac arrhythmias | |
| DE3344086C2 (en) | ||
| SU1097332A1 (en) | Method of treatment of infiltration and dissiminated forms of lung tuberculosis | |
| US4302452A (en) | Use of derivatives of 6α-methylprednisolone as an antiemetic | |
| SU1577795A1 (en) | Method of treating infiltrative tuberculosis of lungs | |
| SU1061818A1 (en) | Method of treatment of pustular psoriasis | |
| SU1034741A1 (en) | Tuberculosis treatment method | |
| SU1194418A1 (en) | Method of treatment of children having purulent destructive pneumonia | |
| SU1232257A1 (en) | Method of treatment of pulmonary tuberculosis | |
| RU2104046C1 (en) | Method to treat pulmonary tuberculosis | |
| SU1191087A1 (en) | Method of treatment of secondary amenorrhea | |
| SU1380752A1 (en) | Method of tuberculinotherapy | |
| SU1573426A1 (en) | Method of treatment of destructive tuberculosis of the lungs | |
| Berrington et al. | Modified leptazol convulsive therapy | |
| SU1205916A1 (en) | Method of treatment of parodontosis | |
| RU1782594C (en) | Method for treating pulmonary tuberculosis | |
| RU1810066C (en) | Acute cardiac insufficiency syndrome treatment method | |
| RU2099056C1 (en) | Method of tuberculosis treatment | |
| JPS6345371B2 (en) | ||
| SU858850A1 (en) | Method of treating posttuberculosis cicatrix changing of tissue | |
| SEUFFERT et al. | Use of diphenylhydantoin in prevention and treatment of cardiac arrhythmias during general anesthesia |